Xponance’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.8M | Buy |
57,219
+5,095
| +10% | +$1.4M | 0.13% | 127 |
|
|
2025
Q1 | $13.8M | Sell |
52,124
-481
| -0.9% | -$128K | 0.13% | 127 |
|
|
2024
Q4 | $12.2M | Buy |
52,605
+1,458
| +3% | +$339K | 0.11% | 143 |
|
|
2024
Q3 | $11.3M | Buy |
51,147
+1,614
| +3% | +$356K | 0.11% | 149 |
|
|
2024
Q2 | $9.74M | Sell |
49,533
-1,059
| -2% | -$208K | 0.1% | 152 |
|
|
2024
Q1 | $10.9M | Buy |
50,592
+3,908
| +8% | +$841K | 0.11% | 151 |
|
|
2023
Q4 | $9.83M | Buy |
46,684
+1,989
| +4% | +$419K | 0.12% | 147 |
|
|
2023
Q3 | $8.95M | Buy |
44,695
+1,400
| +3% | +$280K | 0.12% | 141 |
|
|
2023
Q2 | $8.02M | Sell |
43,295
-394
| -0.9% | -$73K | 0.11% | 166 |
|
|
2023
Q1 | $8.37M | Buy |
43,689
+1,303
| +3% | +$250K | 0.12% | 152 |
|
|
2022
Q4 | $7.13M | Buy |
42,386
+5,394
| +15% | +$907K | 0.12% | 169 |
|
|
2022
Q3 | $6.55M | Buy |
36,992
+2,267
| +7% | +$402K | 0.13% | 145 |
|
|
2022
Q2 | $7.11M | Sell |
34,725
-2,826
| -8% | -$578K | 0.14% | 127 |
|
|
2022
Q1 | $8.93M | Buy |
37,551
+14,627
| +64% | +$3.48M | 0.15% | 122 |
|
|
2021
Q4 | $5.24M | Buy |
22,924
+4,669
| +26% | +$1.07M | 0.08% | 207 |
|
|
2021
Q3 | $3.53M | Sell |
18,255
-1,704
| -9% | -$330K | 0.07% | 236 |
|
|
2021
Q2 | $4.25M | Buy |
19,959
+4,589
| +30% | +$976K | 0.08% | 208 |
|
|
2021
Q1 | $3.14M | Sell |
15,370
-280
| -2% | -$57.2K | 0.07% | 234 |
|
|
2020
Q4 | $2.85M | Buy |
15,650
+1,088
| +7% | +$198K | 0.06% | 251 |
|
|
2020
Q3 | $2.44M | Sell |
14,562
-51
| -0.3% | -$8.53K | 0.06% | 246 |
|
|
2020
Q2 | $2.38M | Buy |
+14,613
| New | +$2.38M | 0.06% | 242 |
|